Evaluation of quality of life scores and family impact scales in pediatric patients with alopecia areata: a cross‐sectional cohort study
International Journal of Dermatology · 2024-10 · 63 (10) · 1414-1420
DOI: 10.1111/ijd.17154 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift International Journal of Dermatology, online erschienen am 22.04.2024. Verfasst von Sera Nur Yücesoy und 7 weiteren Autor:innen. Beteiligte Einrichtung: Cerrahpasa Medical Faculty, Department of Dermatology, Istanbul University-Cerrahpasa, Istanbul, Turkey. Hauptthemen laut MEDLINE: Alopecia Areata, Quality of Life, Severity of Illness Index. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
There are a limited number of studies evaluating the effects of alopecia areata (AA) on the health‐related quality of life (HRQoL) of pediatric patients and their families. This study aimed to assess the HRQoL of pediatric patients with AA and their parents. Materials and methods This single‐center cross‐sectional cohort study included 72 pediatric patients diagnosed with AA. The study was conducted between December 2020 and December 2021 in the dermatology department of a single tertiary center in Turkey. The HRQoL index of the pediatric patients was assessed with the Children's Dermatology Life Quality Index (CDLQI). At the same time, their parents, who were primarily involved in the disease process, were evaluated using the Dermatological Family Impact Scale (DeFIS). An ordinal logistic regression model was used to detect predictors for CDLQI severity.
Results
The mean ± SD CDLQI of the pediatric patients who participated in our study was 8.4 ± 5.3, corresponding to moderate impairment. The highest impairment in CDLQI was observed in the symptoms and feelings domain, while the slightest impairment was observed in the domain of personal relationships ( P < 0.001). There was a statistically significant positive correlation between the Severity of Alopecia Tool (SALT) score and all CDLQI domains, and the most substantial relationship was with the leisure domain ( r = 0.78, P < 0.001). DeFIS scores of female patients were substantially higher than males (25.3 ± 8.6 vs. 17.6 ± 9, P = 0.001).
Conclusion
Our study supports that AA is a disease that significantly impacts the HRQoL of affected children and their families.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cerrahpasa Medical Faculty, Department of Dermatology, Istanbul University-Cerrahpasa, Istanbul, Turkey.
- Department of Psychiatry, Ministry of Health, Arnavutköy State Hospital, Istanbul, Turkey.
- Department of Internal Medicine, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey.
- Department of Psychiatry, Ministry of Health, Sultan 2. Abdulhamid Han Hospital, Istanbul, Turkey.
- Cerrahpasa Medical Faculty, Department of Psychiatry, Istanbul University-Cerrahpasa, Istanbul, Turkey.
ORCID-Profile: Sera Nur Yücesoy
Zitieren
APA
Yücesoy, S. N., Uzunçakmak, T. K., Selçukoğlu, Ö., Aşkın, Ö., Ak, T., Özdil Eser, A., Turan, Ş., & Serdaroğlu, S. (2024). Evaluation of quality of life scores and family impact scales in pediatric patients with alopecia areata: a cross‐sectional cohort study. International Journal of Dermatology, 63(10), 1414-1420. https://doi.org/10.1111/ijd.17154
Vancouver
Yücesoy SN, Uzunçakmak TK, Selçukoğlu Ö, Aşkın Ö, Ak T, Özdil Eser A, et al. Evaluation of quality of life scores and family impact scales in pediatric patients with alopecia areata: a cross‐sectional cohort study. International Journal of Dermatology. 2024;63(10):1414-1420. doi:10.1111/ijd.17154
BibTeX
@article{Ycesoy2024,
author = {Yücesoy, Sera Nur and Uzunçakmak, Tuğba Kevser and Selçukoğlu, Özge and Aşkın, Özge and Ak, Tumay and Özdil Eser, Ayşenur and Turan, Şenol and Serdaroğlu, Server},
title = {Evaluation of quality of life scores and family impact scales in pediatric patients with alopecia areata: a cross‐sectional cohort study},
journal = {International Journal of Dermatology},
year = {2024},
volume = {63},
number = {10},
pages = {1414--1420},
doi = {10.1111/ijd.17154}
}
EUVIMED